Papers
2
Total Citations
305
H-Index
2
About
Sylvain Miraux is a pioneering figure at the intersection of bioprinting and computer-assisted medical intervention. His groundbreaking work established the first *in vivo* bioprinting platform for robotic-assisted surgery, demonstrated in a landmark 2010 study (275 citations) where nano-hydroxyapatite was successfully printed directly into mouse calvarial defects—a foundational proof-of-concept for intraoperative tissue regeneration. This innovation bridges additive manufacturing with clinical robotics, opening new avenues for precise, automated repair of bone and soft tissues. Beyond bioprinting, Miraux has made significant contributions to molecular imaging and vascular targeting. His 2006 work (30 citations) employed *in vivo* biopanning to isolate human single-chain antibodies (scFvs) that home specifically to early atherosclerotic lesions, offering a novel strategy for non-invasive diagnosis and targeted therapy of cardiovascular disease. By integrating phage display technology with preclinical models, he identified molecular probes capable of recognizing diseased endothelium. Miraux’s dual expertise—engineering bioprinting workflows and developing targeted molecular agents—positions him as a unique translational researcher, whose work continues to inspire advances in regenerative medicine, image-guided surgery, and theranostic applications.
Research Focus
Key Achievements
Top Papers
- 1
- 2Identification of Human scFvs Targeting Atherosclerotic Lesions30 citations · 2006